RUDNICK SETH 4
4 · G1 Therapeutics, Inc. · Filed Jun 14, 2019
Insider Transaction Report
Form 4
RUDNICK SETH
Director
Transactions
- Award
Stock Option (right to buy)
2019-06-12+20,000→ 20,000 totalExercise: $18.47Exp: 2029-06-12→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option will vest in their entirety twelve months after June 12, 2019, subject to the Reporting Person's continued service as a director.